Literature DB >> 7243514

Oxygen consumption and temperature control of premature infants in a double-wall incubator.

K H Marks, C A Lee, C D Bolan, M J Maisels.   

Abstract

The effects of a double wall in a forced convection-heated incubator were studied on ten naked, nondistressed, premature infants by measuring their mean skin temperature, esophageal temperature, and oxygen consumption when they were in thermal steady state, with, and without, the double wall in place. The incubator air temperature was maintained within the recommended thermoneutral zone during the consecutive paired experiments. Ambient room temperature and relative humidity were constant and the infant's activity (quiet sleep) and postprandial state were the same in both conditions. Together with a significant rise in operative temperature (P less than .05) induced by the double wall (accounted for by a 0.9 C mean increased in incubator wall temperature nearest the baby), their mean skin temperature and esophageal temperatures increased (P less than .025), while a decrease in oxygen consumption occurred in nine of the ten infants (P less than .05). These findings suggest that the double wall reduced radiant and total heat loss from the baby by diminishing the temperature gradient between the skin and incubator surfaces and that metabolic heat production (oxygen consumption) was reduced when the double wall was in place.

Entities:  

Mesh:

Year:  1981        PMID: 7243514

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  2 in total

Review 1.  Double wall versus single wall incubator for reducing heat loss in very low birth weight infants in incubators.

Authors:  N Laroia; D L Phelps; J Roy
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18

2.  Body temperature instability and respiratory morbidity in the very low birth weight infant: a multiple case, intensive longitudinal study.

Authors:  Jane L Ralphe; Susan G Silva; Robin B Dail; Debra H Brandon
Journal:  BMC Pediatr       Date:  2020-10-20       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.